Earnings Feed
Start Free
|4Dec 21, 4:46 PM ET

BRENNAN DANIEL 4

4 · CATALYST PHARMACEUTICALS, INC. · Filed Dec 21, 2018

Insider Transaction Report

Form 4
Period: 2018-12-19
CATALYST PHARMACEUTICALS, INC.CPRX
BRENNAN DANIEL
Chief Commercial Officer
Transactions
  • Award

    Options to purchase common stock

    2018-12-19+38,333→ 476,666 total
    Exercise: $2.24From: 2020-12-19Exp: 2025-12-19→ Common Stock (38,333 underlying)
  • Award

    Options to purchase common stock

    2018-12-19+38,333→ 438,333 total
    Exercise: $2.24From: 2019-12-19Exp: 2025-12-19→ Common Stock (38,333 underlying)
  • Award

    Options to purchase common stock

    2018-12-19+38,334→ 515,000 total
    Exercise: $2.24From: 2021-12-19Exp: 2025-12-19→ Common Stock (38,334 underlying)

Documents

1 file
  • 4
    form4.xmlPrimary

    FORM 4 FOR 12-19-2018